Blue Matter

The World EPA Congress is coming up soon: 5-6 March in Amsterdam. Visit members of our #MarketAccess team at booth 7. Also, be sure to attend a presentation on 5 March at 5:25 pm by Sam Calderwood >> Building a "Best Practice Organization" in Global Market Access: Insights from Biopharma Leaders. Learn more here: https://lnkd.in/dTusjZX Blue Matter team members attending: Sam Calderwood, Hui Tan, & Yan X. #biotech #pharmaceuticals

NEW >> UK NHS & Indication-Specific Pricing: Potentially exciting update in the UK healthcare landscape: the new NHS commissioning framework now includes formalised terms for indication‐specific pricing. This marks a significant departure from the fixed “lowest price” approach - where a uniform price is set based on the lowest cost‐effective price across recommended indications. That said, while the framework is a notable step forward, its detailed requirements still leave a degree of uncertainty. To qualify for indication‐specific pricing, companies must meet strict criteria - demonstrating an unmet clinical need, providing robust evidence that a uniform price would reduce total revenue, ensuring the availability of high‐quality data for each indication, and proving significant cost‐effectiveness differentiation. Additionally, companies will not know if their product will be eligible for this flexible pricing mechanism until they have formally engaged in the NICE process. In essence, while this move has the potential to better align prices with clinical value and unlock access for patients, it also demands proactive, detailed engagement from manufacturers to explore the framework opportunity successfully. Furthermore, it still falls short of alternative approaches such as weighted net pricing based on expected patient volume across reimbursed indications, as employed by other European markets. If interested to discuss further, reach out to Yan X., Sam Calderwood, or Hui Tan from our Global Market Access team! You can also contact us via our website: https://lnkd.in/eEyUTs5B #pharmaceuticals #biotech #NHS

NEW >> Julia Margulis takes a look at the current state of the #CNS market, highlighting the trends & therapies that will drive innovation in 2025 & beyond. Get the #whitepaper here >> https://lnkd.in/eb8hNnnp #alzheimers #biotech #pharmaceutical #neuroimmunology

What's in store for the #oncology market in 2025? Check out our latest paper providing an outlook on the innovations, trends, & therapies that will shape the rest of this year in #cancerresearch >> https://lnkd.in/ef26gskn Authors: Naval Shanware, Mahazabeen Sayyed, Tahel Noy, NINAD AGASHE, Ph.D. #cancer #biopharma #pharmaceuticals #biotech #cancertherapies

We looked at nearly 300 launches to see what factors correlated most with commercial success. In this article, Antonio Iervolino shares some of the findings and introduces a framework for a peak-performance go-to-market operation. >> https://lnkd.in/gdqnzXuG #biotech #pharmaceuticals #biopharma #PharmaceuticalLaunch

The World EPA Congress is only a month away: 5-6 March in Amsterdam. Members of our #MarketAccess team will be there. Visit us at booth no. 7 & don't miss a presentation on 5 March at 5:25 pm by Sam Calderwood >> Building a "Best Practice Organization" in Global Market Access: Insights from Biopharma Leaders Learn more here: https://lnkd.in/dTusjZX Blue Matter team members attending: Yan X., Hui Tan, Sam Calderwood #biotech #pharmaceuticals

Exciting times! The Blue Matter Insights & analytics team in India has officially moved into our new office—a space designed to inspire, connect, & elevate our work. This move symbolizes our dedication to progress, teamwork, & achieving new milestones. Same mission, new home, endless possibilities! #Innovation #NewOffice #TheFutureIsBright

Ready for your next #ConsultingCareer opportunity? Check out this role currently open in our Mumbai office >> https://lnkd.in/enkSDaE6 #consulting #consultingjobs

NEW >> The #CNS market is a broad & complex one. In this article, Julia Margulis explores some of the innovations & trends that will shape CNS therapeutics in 2025 & beyond. Read it here: https://lnkd.in/eHuxKApq #pharmaceutical #biotech #alzheimers #CNSTherapeutics #neuroimmunology

Thinking about joining the Blue Matter team? Now might be the time, with great #consulting opportunities available in San Francisco & Boston! Learn more & apply here: https://lnkd.in/eepHR7D #consultingjobs #consultingcareers #consultingopportunities